1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow REP 2055: new trials by email Literature Review of REP 2055 trials Research Report on REP 2055
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients REP 2055 - Hepatitis B, Chronic | Phase 1 / Phase 2 | Completed | Replicor Inc. | 8 | 2009-01-01 | 2016-01-05 |
Replicor Inc. (1)
Bangladesh (1)